← The SEC Ephemeris: the whole map
ViiV Healthcare Company CABENUVA®
In the graph: all 2 documents (5 pages).
- Application
- NDA 212888
- Ticker
- ViiV Healthcare Company
- Product
- CABENUVA®
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- December 19, 2019 · December 19, 2019
From FDA letters and SEC filings. Not investment or medical advice.